Ibrahim Nahit Sendur

Dr. Ibrahim Nahit Sendur

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
SKSanem Kayhan
Sanem Kayhan
SHSema Hepsen
Sema Hepsen
HKHatice Kozan Kalkisim
Hatice Kozan Kalkisim
ISIbrahim Nahit Sendur
Ibrahim Nahit Sendur
FAFatma Aybala Altay
Fatma Aybala Altay
AYAli Yalcindag
Ali Yalcindag
Objective: This study aims to evaluate potential pancreas endocrine damage due to SARS-CoV-2 by measuring β-cell autoantibodies in COVID-19 patients. Subjects and methods: Between June and July 2020, 95 inpatients with a positive COVID-19 test result after polymerase-chain-reaction (PCR) and who met the inclusion criteria were enrolled in our study. Laboratory parameters that belong to glucose metabolism and β-cell autoantibodies, including anti-islet, anti-glutamic acid decarboxylase, and anti-insulin autoantibodies, were measured. β-cell autoantibodies levels of the patients were measured during [...] ABSTRACT Objective: This study aims to evaluate potential pancreas endocrine damage due to SARS-CoV-2 by measuring β-cell autoantibodies in COVID-19 patients. Subjects and methods: Between June and July 2020, 95 inpatients with a positive COVID-19 test result after polymerase-chain-reaction (PCR) and who met the inclusion criteria were enrolled in our study. Laboratory parameters that belong to glucose metabolism and β-cell autoantibodies, including anti-islet, anti-glutamic acid decarboxylase, and anti-insulin autoantibodies, were measured. β-cell autoantibodies levels of the patients were measured during

20 August 2026 in Akademik Gastroenteroloji Dergisi
Verified
Journal Article
Closed access
BOBengi Ozturk
Bengi Ozturk
ISIbrahim Nahit Sendur
Ibrahim Nahit Sendur
MÇMUHAMMET FURKAN ÇAKMAK
MUHAMMET FURKAN ÇAKMAK
TKTaylan Kav
Taylan Kav
Giriş ve Amaç: Crohn hastalığında cerrahi gereksinimi, hastalık prognozunu ve yaşam kalitesini önemli ölçüde etkileyen temel klinik sonlanımlardan biridir. Cerrahi gereksinimini öngören risk faktörlerinin belirlenmesi, yüksek riskli hastaların erken tanınmasına ve uygun tedavi stratejilerinin geliştirilmesine katkı sağlayabilir. Bu çalışmada, Crohn hastalarında majör cerrahi gereksinimi ile ilişkili klinik, demografik ve laboratuvar faktörlerinin değerlendirilmesi amaçlandı. Gereç ve Yöntem: Hacettepe Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı’nda takip edilen Crohn hastalarının verileri retrospektif olarak incelendi. Demografik özellikler, Montreal sınıflaması, vücut kitle indeksi, C-reaktif protein, hemoglobin, albümin, Crohn Hastalığı Aktivite İndeksi, Crohn Hastalığı için Basitleştirilmiş Endoskopik Skorlama Sistemi skorları değerlendirildi. Cerrahi öyküsü olan ve olmayan hastalar karşılaştırıldı. Anlamlı bulunan değişkenler çok değişkenli lojistik regresyon analizi ile incelendi. Bulgular: Toplam 86 hastanın 14’ünde (%16,3) cerrahi öyküsü mevcuttu. Cerrahi uygulanan hastalarda; vücut kitle indeksi, albümin ve hemoglobin düzeyleri anlamlı olarak daha düşük, C-reaktif protein düzeyi ise daha yüksekti (p < 0,05). Kategorik analizde vücut kitle indeksi ≤ 18,5 kg/m², albümin < 3,5 g/dL, anemi ve C-reaktif protein > 5 mg/L cerrahi öyküsü ile ilişkili bulundu. Çok değişkenli analizde yalnızca vücut kitle indeksi ≤ 18,5 kg/m² bağımsız risk faktörü olarak saptandı (Odds oranı = 13,659; %95 Güven aralığı: 1,135 - 164,434; p = 0,039). Sonuç: Düşük vücut kitle indeksi, Crohn hastalarında majör cerrahi gereksinimi ile ilişkili görünmektedir. Hipoalbüminemi, anemi ve yüksek C-reaktif protein cerrahi gereksinimi ile ilişkili olmakla birlikte bağımsız belirleyiciler değildi. Bulguların daha geniş, prospektif çalışmalarla doğrulanması gerekmektedir.

18 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ISIbrahim Nahit Sendur
Ibrahim Nahit Sendur
UMUmit Yavuz Malkan
Umit Yavuz Malkan
Introduction: In the recent years alternate day dosing has been recommended in iron deficieny treatment. The aim of this study is to compare the efficacy and side effects of oral iron treatments given daily 1x1, alternate day 1x1 and 2x1 alternate day dosing in iron deficieny anemia patients. Methods: A total of 52 patients with a diagnosis of iron deficiency anemia with serum ferritin level of 25 µg/L or less were included in this retrospective study. Statistical analyzes were done with SPSS V.25. Results: The patients included in our study were between the ages of 18-51. All of the patients included in the study were female. A statistically significant increase was found between 0-14 days(p<0.001), 14-28 days(p<0.001) and 0-28 days(p<0.001) hemoglobin values in all patients. There was no statistically significant difference between 0-14 days (p=0.397) and 0-28 days(p=0.310) ferritin values in all patients. A statistically significant difference was found between 14-28 days(p0.05). The incidence of metallic taste and bloating symptoms was found to be statistically significant in the third control in the group with 2x1 drug use alternate day (p=0.094). Discussion: The only difference in efficacy was observed in ferritin values between 14th and 28th days. The increase in ferritin values was higher in the group that used 1x1 oral iron every day. However, since no difference was observed between the groups in terms of ferritin and hemoglobin values on days 0 and 28, all three groups were considered equally efficient. Side effects were mainly gastrointestinal side effects. Since the group that received 2x1 oral treatment alternate day had a statistically significantly higher rate of side effects, the patients’ treatment tolerance will be lower compared to the other groups. In conlusion, there is no difference in efficacy and side effects between the patient groups receiving 1x1 daily and 1x1 alternate day oral iron therapy, so 1x1 use alternate day is the most appropriate treatment method for oral iron therapy in terms of patient tolerance, adherence to treatment and pharmacoeconomics.

1 April 2025 in OBM Transplantation
Verified
Journal Article
Open access
PDF file
ISIbrahim Nahit Sendur
Ibrahim Nahit Sendur
BKBüşra Köksoy
Büşra Köksoy
HBhatice yasemin Balaban
hatice yasemin Balaban
Cytomegalovirus (CMV) remains a significant cause of morbidity and mortality in solid organ transplant (SOT) recipients. Despite advancements in prophylaxis and antiviral therapy, CMV continues to pose clinical challenges in transplant medicine. This review provides a comprehensive overview of CMV, exploring its pathophysiology, epidemiology, and clinical presentation in SOT patients, in whom CMV infection can lead to direct organ involvement and systemic symptoms. Additionally, CMV has indirect effects, including graft dysfunction and an increased risk of opportunistic infections. We examine the immune responses to CMV, focusing on the roles of both innate and adaptive immunity. The importance of personalized prophylaxis and preemptive therapy is emphasized based on serostatus and individual risk factors. Furthermore, this review discusses resistance mechanisms to standard therapies exploring alternative treatments.

25 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BOBengi Ozturk
Bengi Ozturk
MÇMUHAMMET FURKAN ÇAKMAK
MUHAMMET FURKAN ÇAKMAK
AOAbdurrahman Ozkan
Abdurrahman Ozkan
ISIbrahim Nahit Sendur
Ibrahim Nahit Sendur
OKOnur Keskin
Onur Keskin
TKTaylan Kav
Taylan Kav
Background/Objectives: Gaucher disease (GD) is a rare lysosomal storage disorder with heterogeneous and often nonspecific clinical manifestations. Despite increasing awareness of Gaucher disease (GD), diagnostic delay remains a clinical challenge because of its heterogeneous and nonspecific presentation. This study evaluated the diagnostic journey of patients with GD, with particular emphasis on diagnostic delay, healthcare specialties encountered before diagnosis, and the involvement of gastroenterology in the diagnostic pathway. Materials and Methods: Patients with GD followed at the Hacettepe University Department of Gastroenterology between January 2014 and December 2024 were included. Demographic and clinical characteristics, age at symptom onset and diagnosis, diagnosis delay, medical specialties consulted before diagnosis, diagnostic methods, GD subtype, and treatment data were obtained from hospital records. Continuous variables were summarized as medians, minimum-maximum values, or interquartile ranges as appropriate, while categorical variables were summarized as frequencies and percentages. Results: Of the 34 patients, 22 (64.7%) were female, and 12 (35.3%) were male. The median age at diagnosis was 17.5 years [minimum(min)–maximum(max), 1–69], and the median age at symptom onset was 9 years (min–max, 1–44). Diagnostic-delay data were available for 21 patients. The median time from symptom onset to diagnosis was 1 year (range, 0–19); 11/21 patients (52.4%) were diagnosed within 1 year, whereas 5/21 (23.8%) experienced a diagnostic delay of ≥5 years. Among patients with available data on the diagnosing specialty, 42.9% were diagnosed in pediatric gastroenterology and 28.6% in adult gastroenterology. Among 23 patients with available prediagnostic referral data, 8 (34.8%) had consulted two or more different medical specialties before diagnosis. Conclusions: Although more than half of the patients with available diagnostic-delay data were diagnosed within 1 year of symptom onset, nearly one-quarter experienced delays of ≥5 years. Gastroenterology services represented a frequent point of diagnosis in this referral-center cohort, although this observation should be interpreted in light of the gastroenterology-based study setting and associated referral and selection bias. These findings should be interpreted cautiously given the small sample size and missing data. Greater awareness of GD in patients presenting with unexplained hepatosplenomegaly and/or cytopenias, together with timely use of disease-specific biochemical and molecular testing, may help shorten the diagnostic journey and reduce unnecessary diagnostic procedures.